ColestZen has announced its 2026 launch with a daily capsule positioned as a cholesterol support supplement. According to the release, the product is being introduced in the US, UK, Canada and Australia as part of a broader rollout focused on cardiovascular wellness.
The company says the ColestZen formula combines 18 botanical ingredients with essential micronutrients. Based on the announcement, the capsule is designed to complement healthy cholesterol management while also supporting heart health and normal circulation.
The launch places ColestZen in the growing market for daily wellness supplements aimed at people looking for non-prescription options to support cardiovascular routines. The product description highlights its ingredient blend and supplement facts as key selling points for consumers comparing cholesterol support capsules.
While the announcement centers on benefits tied to healthy cholesterol support, the release presents ColestZen as a general wellness supplement rather than a treatment. The 2026 introduction signals the brand’s push into multiple English-speaking markets with a formula built around plant-based ingredients and micronutrient support.